Avanos Medical (NYSE:AVNS – Get Free Report) was upgraded by analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a research report issued to clients and investors on Tuesday.
Avanos Medical Stock Up 0.7 %
Avanos Medical stock traded up $0.15 during mid-day trading on Tuesday, reaching $22.80. 180,556 shares of the company were exchanged, compared to its average volume of 239,375. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.49 and a current ratio of 2.28. The firm has a market cap of $1.05 billion, a P/E ratio of -17.14 and a beta of 0.91. The business has a fifty day moving average of $23.44 and a 200 day moving average of $21.27. Avanos Medical has a 12-month low of $17.24 and a 12-month high of $25.36.
Avanos Medical (NYSE:AVNS – Get Free Report) last released its quarterly earnings results on Wednesday, July 31st. The company reported $0.34 EPS for the quarter, beating the consensus estimate of $0.29 by $0.05. Avanos Medical had a net margin of 1.13% and a return on equity of 4.48%. The business had revenue of $171.70 million during the quarter, compared to analyst estimates of $170.67 million. During the same period in the prior year, the firm posted $0.24 earnings per share. The company’s quarterly revenue was up 1.4% on a year-over-year basis. Research analysts anticipate that Avanos Medical will post 1.39 earnings per share for the current fiscal year.
Institutional Trading of Avanos Medical
Avanos Medical Company Profile
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Featured Articles
- Five stocks we like better than Avanos Medical
- Why Are These Companies Considered Blue Chips?
- Goldman Sachs Earnings Reveal Market Moves Investors Can’t Ignore
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- AMD Gains Momentum With AI: Can It Beat Expectations?
- What is MarketRankā¢? How to Use it
- Lithium Grab: 2 Lithium Stocks That Could Be Takeover Targets
Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.